Linking Metabolic Reprogramming, Plasticity and Tumor Progression

• Main Authors: Oleg Shuvalov, Alexandra Daks, Olga Fedorova, Alexey Petukhov, Nickolai Barlev
• Format: Article
• Language: English
• Published: MDPI AG 2021-02-01
• Series: Cancers
• Subjects: metabolic reprograming; cancer metabolism; aerobic glycolysis; lipid metabolism; one-carbon metabolism; cancer therapy
• Online Access: https://www.mdpi.com/2072-6694/13/4/762

The specific molecular features of cancer cells that distinguish them from the normal ones are denoted as “hallmarks of cancer”. One of the critical hallmarks of cancer is an altered metabolism which provides tumor cells with energy and structural resources necessary for rapid proliferation. The key feature of a cancer-reprogrammed metabolism is its plasticity, allowing cancer cells to better adapt to various conditions and to oppose different therapies. Furthermore, the alterations of metabolic pathways in malignant cells are heterogeneous and are defined by several factors including the tissue of origin, driving mutations, and microenvironment. In the present review, we discuss the key features of metabolic reprogramming and plasticity associated with different stages of tumor, from primary tumors to metastases. We also provide evidence of the successful usage of metabolic drugs in anticancer therapy. Finally, we highlight new promising targets for the development of new metabolic drugs.